Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Bruker Spatial Biology Inc. has 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 3 distinct art units and 4 distinct examiners. This distribution indicates that each of the 4 pending actions is being reviewed by a different individual.
SPENCE, JENNIFER SUZANNE is the busiest examiner for the company, with 1 pending office action currently under review. This is one of the 4 total pending actions for the portfolio. The involvement of 4 distinct examiners across 3 distinct art units for the pending actions suggests a diverse prosecution landscape for the company's current matters. Practitioners should expect that each of the 4 pending actions will be handled independently, with minimal concentration across the 3 art units.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §103 only | 2 (50%) |
| §112 only | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SPENCE, JENNIFER SUZANNE | 1 | 66.9% | +46.0% |
| MONTGOMERY, ANN Y | 1 | 69.0% | +27.7% |
| BEVERIDGE, CONNOR HAMMOND | 1 | 0.0% | +0.0% |
| KIM, SEONG JONG | 1 | 25.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18172771 | CHEMICAL COMPOSITIONS AND METHODS OF USE | KIM, SEONG JONG | 8d overdue |
| 18030889 | METHODS, SYSTEMS AND DEVICES FOR PROCESSING SEQUENCE DATA | BEVERIDGE, CONNOR HAMMOND | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18673148 | FUNCTIONALIZED WELL PLATE, METHODS OF PREPARATION AND USE THEREOF | SPENCE, JENNIFER SUZANNE | 1d overdue |
| 18332207 | Methods for Identification of Exchangeable MHC Binding Peptides and Methods of Use Thereof | MONTGOMERY, ANN Y | — |
| Art Unit | Apps |
|---|---|
| 1633 | 1 |
| 1678 | 1 |
| 1621 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18673148 | FUNCTIONALIZED WELL PLATE, METHODS OF PREPARATION AND USE THEREOF | SPENCE, JENNIFER SUZANNE | 1633 | §103 | Final Rejection | 1d overdue | Pending | May 23, 2024 |
| 18332207 | Methods for Identification of Exchangeable MHC Binding Peptides and Methods of Use Thereof | MONTGOMERY, ANN Y | 1678 | §112 | Non-Final OA | — | Pending | Jun 09, 2023 |
| 18030889 | METHODS, SYSTEMS AND DEVICES FOR PROCESSING SEQUENCE DATA | BEVERIDGE, CONNOR HAMMOND | — | §101§103 | Non-Final OA | — | Pending | Apr 07, 2023 |
| 18172771 | CHEMICAL COMPOSITIONS AND METHODS OF USE | KIM, SEONG JONG | 1621 | §103Other | Final Rejection | 8d overdue | Pending | Feb 22, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial